4 results match your criteria: "Union Jiangbei Hospital of Huazhong University of Science and Technology[Affiliation]"
Buyang Huanwu Decoction suppresses ischemic stroke by suppressing glycolysis and cell apoptosis in rat brain microvascular endothelial cells.
Brain Res Bull
September 2024
Union Jiangbei Hospital of Huazhong University of Science and Technology, No. 111, Chenggong Avenue, Caidian District, Wuhan, Hubei 430100, China.
Article Synopsis
- Buyang Huanwu Decoction (BHD) is commonly used in Chinese medicine to treat and prevent ischemic cerebral vascular diseases, and this study aims to explore its effects on ischemic stroke (IS) and the mechanisms behind it.
- The research used rat models to assess brain injury, neurological function, and cell viability, revealing that BHD treatment reduced brain infarction size and improved neurological scores while decreasing blood-brain barrier permeability.
- The findings indicate that BHD works by inhibiting glycolysis and apoptosis in brain cells, specifically by lowering certain lactylation proteins and affecting the activity of the apoptotic protein Apaf-1, thereby slowing down the advancement of ischemic stroke.
Comparison of ultrasound features and lesion sites in dysfunctional arteriovenous fistula.
Ren Fail
December 2024
Department of Nephrology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
This study aimed to investigate ultrasound features of arteriovenous fistula stenosis and their relationship with primary patency after percutaneous transluminal angioplasty (post-intervention primary patency) and compare this classification with that using lesion location. Hemodialysis patients who underwent ultrasound-guided percutaneous transluminal angioplasty for arteriovenous fistula stenosis from July 2020 to December 2021 were retrospectively evaluated. Lesions (excluding inflow arteries) were categorized into five groups based on ultrasound features, and the clinical characteristics and risk factors affecting the post-intervention primary patency of the arteriovenous fistula were analyzed.
View Article and Find Full Text PDFRecurrent syncope due to central venous occlusion in a patient undergoing hemodialysis.
J Vasc Access
July 2024
Department of Nephrology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China.
A 66-year-old male patient receiving maintenance hemodialysis with arteriovenous fistula of the right upper limb was admitted to the hospital because of intermittent syncope, dizziness, and distension. Central venography indicated occlusion of the right brachiocephalic vein (RBV), and the contrast agent flowed from the right internal jugular vein into the intracranial vein, then into the contralateral internal jugular vein, and finally returned into the superior vena cava. Percutaneous transluminal angioplasty was performed to dilate the RBV.
View Article and Find Full Text PDFEffectiveness of therapeutic hypothermia for mild neonatal encephalopathy: A protocol for systematic review and meta-analysis.
Medicine (Baltimore)
May 2022
Department of Respiratory Medicine, Union Jiangbei Hospital of Huazhong University of Science and Technology, Hubei, China.
Background: Neonates with moderate to severe encephalopathy benefit significantly from therapeutic hypothermia, with reduced risk of death or disability. However, the need for therapeutic hypothermia for mild neonatal encephalopathy (NE) remains unclear. Therefore, we conducted a protocol for systematic review and meta-analysis to provide evidence supporting therapeutic hypothermia for term or near term neonates with mild NE, including findings of recent long-term outcome studies, as well as novel adjunctive therapies to augment neurodevelopmental outcomes for neonates with NE who receive therapeutic hypothermia.
View Article and Find Full Text PDF